東和薬品(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4553/E00974TOWA PHARMACEUTICAL CO., LTD.
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2023/04/28日証協無担保40,000株-21.72%0株0%1,500株+252.94%
2023/04/28日証協有担保107,014株-54.26%138,138株0%12,291株+129.05%
2023/04/21日証協無担保51,100株0%0株0%425株-52.78%
2023/04/21日証協有担保233,959株+12.24%0株-100%5,366株-83.54%
2023/04/14日証協無担保0株-100%0株0%900株-91.67%
2023/04/14日証協有担保208,452株-24.5%136,467株+14.26%32,600株-86.32%
2023/04/07日証協無担保2,400株0%0株-100%10,808株-91.62%
2023/04/07日証協有担保276,106株+6.43%119,434株+272.84%238,331株-20.91%
2023/03/31日証協無担保0株0%1,100株0%128,947株+8490.74%
2023/03/31日証協有担保259,420株+229.05%32,034株+309.96%301,355株+19.06%
2023/03/24日証協無担保0株0%0株0%1,501株-58.43%
2023/03/24日証協有担保78,838株-0.91%7,814株-68.78%253,106株+442.04%
2023/03/17日証協無担保0株0%0株0%3,611株-87.24%
2023/03/17日証協有担保79,565株+71.11%25,028株+491.96%46,695株-56.36%
2023/03/10日証協無担保0株-100%0株0%28,305株-44.4%
2023/03/10日証協有担保46,500株+3.01%4,228株+46.1%107,000株+131.45%
2023/03/03日証協無担保2,180株-93.71%0株0%50,904株+742.92%
2023/03/03日証協有担保45,142株-39.36%2,894株-56.79%46,231株-66.65%
2023/02/24日証協無担保34,640株+3364%0株0%6,039株-42.33%
2023/02/24日証協有担保74,443株+25.06%6,697株-75.73%138,637株+38.67%
2023/02/17日証協無担保1,000株0%0株0%10,472株+1200.87%
2023/02/17日証協有担保59,524株-17.79%27,594株0%99,976株+16.01%
2023/02/10日証協無担保0株0%0株0%805株-92.55%
2023/02/10日証協有担保72,409株+110.3%0株-100%86,182株+25.08%
2023/02/03日証協無担保0株0%0株0%10,800株+3500%
2023/02/03日証協有担保34,431株+79.05%4,100株+247.46%68,900株-26.69%
2023/01/27日証協無担保0株-100%0株0%300株-88.46%
2023/01/27日証協有担保19,230株-3.69%1,180株-89.82%93,982株+24.57%
2023/01/20日証協無担保28,500株+429.74%0株-100%2,600株+224.59%
2023/01/20日証協有担保19,966株+72.81%11,597株-55.04%75,447株-5.19%
2023/01/13日証協無担保5,380株0%400株0%801株-52.88%
2023/01/13日証協有担保11,554株-81.87%25,794株+10.26%79,579株-10.86%
2023/01/06日証協無担保0株0%0株-100%1,700株-92.58%
2023/01/06日証協有担保63,733株-51.63%23,394株+47.16%89,279株+127.17%
2022/12/30日証協無担保0株-100%300株0%22,900株+2762.5%
2022/12/30日証協有担保131,749株+80.97%15,897株+48.61%39,300株-64.4%
2022/12/23日証協無担保522株-95.55%0株0%800株+700%
2022/12/23日証協有担保72,803株+539.63%10,697株-28.67%110,390株-12.39%

※株式分割は考慮していませんのでご注意ください。

Page Top